Browsing Centre for Cancer Prevention by Author "Szanto, A"
Now showing items 1-1 of 1
-
EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study
Zauderer, MG; Szlosarek, PW; Le Moulec, S; Popat, S; Taylor, P; Planchard, D; Scherpereel, A; Koczywas, M; Forster, M; Cameron, RB (2022)